Page 1180 - Hematology_ Basic Principles and Practice ( PDFDrive )

1028 Part VII Hematologic Malignancies

gliomas, meningiomas, and myeloid malignancies, occur with 13. Holmfeldt L, Wei L, Diaz-Flores E, et al: The genomic landscape of
increased frequency in patients treated with regimens that included hypodiploid acute lymphoblastic leukemia. Nat Genet 45(3):242–252,
irradiation, epipodophyllotoxins, or alkylating agents. 31 2013.
14. Arico M, Schrappe M, Hunger SP, et al: Clinical outcome of chil-
dren with newly diagnosed Philadelphia chromosome-positive acute
FUTURE DIRECTIONS lymphoblastic leukemia treated between 1995 and 2005. J Clin Oncol
28(31):4755–4761, 2010.
As the cure rate approaches 90%, treatment response assessed by 15. Schultz KR, Carroll A, Heerema NA, et al: Long-term follow-up of ima-
MRD measurements of submicroscopic leukemia has emerged as a tinib in pediatric Philadelphia chromosome-positive acute lymphoblastic
powerful and independent prognostic indicator for gauging the leukemia: Children’s Oncology Group study AALL0031. Leukemia
intensity of ALL therapy. Children at high risk of relapse may now 28(7):1467–1471, 2014.
benefit from early intensification of therapy. The next goal is to 16. Pui CH, Pei D, Coustan-Smith E, et al: Clinical utility of sequential
reduce the intensity of therapy in children at very low risk of relapse, minimal residual disease measurements in the context of risk-based
hence avoiding undue toxicity. The successful elimination of preven- therapy in childhood acute lymphoblastic leukaemia: a prospective study.
tive cranial irradiation indicates that treatment reduction is feasible Lancet Oncol 16(4):465–474, 2015.
if done with caution and appropriate substitution with less toxic 17. Eden T, Pieters R, Richards S, et al: Systematic review of the addition of
alternatives. Global genome analysis, in addition to refining leukemia vincristine plus steroid pulses in maintenance treatment for childhood
classification, is helping identify potential molecular targets for acute lymphoblastic leukaemia—an individual patient data meta-analysis
therapy. Expanding the application of pharmacogenomics, a science involving 5,659 children. Br J Haematol 149(5):722–733, 2010.
that aims to define the genetic determinants of drug effects, will allow 18. Pui CH, Campana D, Pei D, et al: Treating childhood acute lymphoblastic
further personalized therapy in the future. leukemia without cranial irradiation. N Engl J Med 360(26):2730–2741,
2009.
19. Teuffel O, Kuster SP, Hunger SP, et al: Dexamethasone versus prednisone
REFERENCES for induction therapy in childhood acute lymphoblastic leukemia: a
systematic review and meta-analysis. Leukemia 25(8):1232–1238,
1. Pui CH, Yang JJ, Hunger SP, et al: Childhood acute lymphoblastic 2011.
leukemia: progress through collaboration. J Clin Oncol 33:2938–2948, 20. van den Berg H: Asparaginase revisited. Leuk Lymphoma 52(2):168–178,
2015. 2011.
2. Hunger SP, Mullighan CG: Acute lymphoblastic leukemia in children. 21. Matloub Y, Bostrom BC, Hunger SP, et al: Escalating intravenous
N Engl J Med 373(16):1541–1552, 2015. methotrexate improves event-free survival in children with standard-risk
3. Pui CH, Robison LL, Look AT: Acute lymphoblastic leukaemia. Lancet acute lymphoblastic leukemia: a report from the Children’s Oncology
371(9617):1030–1043, 2008. Group. Blood 118(2):243–251, 2011.
4. Bienemann K, Burkhardt B, Modlich S, et al: Promising therapy results 22. Bhojwani D, Pui CH: Relapsed childhood acute lymphoblastic leukae-
for lymphoid malignancies in children with chromosomal breakage mia. Lancet Oncol 14(6):e205–e217, 2013.
syndromes (Ataxia teleangiectasia or Nijmegen-breakage syndrome): a 23. Pulsipher MA, Peters C, Pui CH: High-risk pediatric acute lympho-
retrospective survey. Br J Haematol 155(4):468–476, 2011. blastic leukemia: to transplant or not to transplant? Biol Blood Marrow
5. Schmiegelow K, Lausten Thomsen U, Baruchel A, et al: High concor- Transplant 17(1 Suppl):S137–S148, 2011.
dance of subtypes of childhood acute lymphoblastic leukemia within 24. Bailey LC, Lange BJ, Rheingold SR, et al: Bone-marrow relapse in
families: lessons from sibships with multiple cases of leukemia. Leukemia paediatric acute lymphoblastic leukaemia. Lancet Oncol 9(9):873–883,
26(4):675–681, 2012. 2008.
6. Zelent A, Greaves M, Enver T: Role of the TEL-AML1 fusion gene in 25. Gaynon PS, Qu RP, Chappell RJ, et al: Survival after relapse in childhood
the molecular pathogenesis of childhood acute lymphoblastic leukaemia. acute lymphoblastic leukemia: impact of site and time to first relapse—
Oncogene 23(24):4275–4283, 2004. the Children’s Cancer Group Experience. Cancer 82(7):1387–1395,
7. Pui CH, Carroll WL, Meshinchi S, et al: Biology, risk stratification, 1998.
and therapy of pediatric acute leukemias: an update. J Clin Oncol 26. Mullighan CG, Zhang J, Kasper LH, et al: CREBBP mutations in
29(5):551–565, 2011. relapsed acute lymphoblastic leukaemia. Nature 471(7337):235–239,
8. Zhang J, Ding L, Holmfeldt L, et al: The genetic basis of early T-cell 2011.
precursor acute lymphoblastic leukaemia. Nature 481(7380):157–163, 27. Howard SC, Jones DP, Pui CH: The tumor lysis syndrome. N Engl J
2012. Med 364(19):1844–1854, 2011.
9. Harvey RC, Mullighan CG, Chen IM, et al: Rearrangement of CRLF2 is 28. Haidar C, Jeha S: Drug interactions in childhood cancer. Lancet Oncol
associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/ 12(1):92–99, 2011.
Latino ethnicity, and a poor outcome in pediatric B-progenitor acute 29. Essig S, Li Q, Chen Y, et al: Risk of late effects of treatment in children
lymphoblastic leukemia. Blood 115(26):5312–5321, 2010. newly diagnosed with standard-risk acute lymphoblastic leukaemia: a
10. Roberts KG, Li Y, Payne-Turner D, et al: Targetable kinase-activating report from the Childhood Cancer Survivor Study cohort. Lancet Oncol
lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med 15(8):841–851, 2014.
371(11):1005–1015, 2014. 30. Zhang J, Nichols KE, Downing JR: Germline mutations in predisposi-
11. Trevino LR, Yang W, French D, et al: Germline genomic variants tion genes in pediatric cancer. N Engl J Med 374(14):1391, 2016.
associated with childhood acute lymphoblastic leukemia. Nat Genet 31. Walter AW, Hancock ML, Pui CH, et al: Secondary brain tumors in
41(9):1001–1005, 2009. children treated for acute lymphoblastic leukemia at St Jude Children’s
12. Shah S, Schrade KA, Waanders E, et al: A recurrent germline PAX5 Research Hospital. J Clin Oncol 16(12):3761–3767, 1998.
mutation confers susceptibility to pre-B cell acute lymphoblastic leuke-
mia. Nat Genet 45(10):1226–1231, 2013.